Related Experiment Video
Updated: May 12, 2026

03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
Sarcopenia, a neurogenic syndrome?
1ST013a, Department of Rehabilitation Sciences, Hong Kong Polytechnic University, Hong Kong.
Journal of Aging Research
|April 12, 2013
Summary
Sarcopenia, an age-related loss of muscle mass and strength, may originate from the nervous system. Understanding this neurogenic trigger is crucial for developing effective treatments for older adults.
Area of Science:
- Gerontology and Neuroscience
- Muscle physiology and aging research
Background:
- Sarcopenia is a prevalent aging-associated condition characterized by decreased muscle mass and strength.
- The global older adult population is increasing, amplifying the impact and prevalence of sarcopenia.
- Current therapeutic interventions for sarcopenia are limited, highlighting the need for deeper mechanistic understanding.
Purpose of the Study:
- To investigate the underlying mechanisms of sarcopenia pathogenesis.
- To propose a novel hypothesis regarding the primary trigger of sarcopenia.
- To inform the development of more effective therapeutic strategies and a standardized characterization of sarcopenia.
Main Methods:
- Review of existing literature on sarcopenia and aging.
- Analysis of the relationship between the nervous system and muscular system in aging.
- Hypothesis generation based on neurogenic origins of sarcopenia.
Main Results:
- Sarcopenia is multifactorial, with current research often focusing on muscular factors.
- The intimate relationship between motor neurons and muscle fibers suggests a potential neurogenic origin.
- Both motor neurons and muscle fibers are influenced by the cellular environment and physiological activity.
Conclusions:
- The primary trigger of sarcopenia may be neurogenic, stemming from the motor neuron-muscle fiber unit.
- Further research into the neurogenic mechanisms of sarcopenia is essential.
- A unified characterization and effective treatments for sarcopenia are urgently needed.
Related Concept Videos
Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
